APOE’s role in tau pathology has drawn much interest both within AD research and among researchers studying related tau-related diseases such as FTD (frontotemporal dementia), CTE (chronic traumatic encephalopathy), and CBD (corticobasal degeneration). The gene discussed is MAPT; the disease is Alzheimer disease.